A randomized, double blind, placebo‐controlled pilot trial of the safety and efficacy of atorvastatin in children with elevated low‐density lipoprotein cholesterol (LDL‐C) and type 1 diabetes

By  

PEDIATRIC DIABETES (ELECTRONIC), Vol. 16, Iss. 2, 2015-03 ,pp. : 79-89

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States

By Fox Kathleen M.   Gandhi Sanjay K.   Ohsfeldt Robert L.   Blasetto James W.   Bays Harold E.  

Current Medical Research and Opinion, Vol. 23, Iss. 9, 2007-09 ,pp. : 2125-2133

Informa Healthcare

Access to resources Recommend Favorite

Measurement of Low‐Density Lipoprotein Cholesterol in Assessment and Management of Cardiovascular Disease Risk

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 96, Iss. 1, 2014-07 ,pp. : 20-22

John Wiley & Sons Inc

Access to resources Recommend Favorite

Perspectives on low-density lipoprotein cholesterol goal achievement

By Catapano Alberico L.  

Current Medical Research and Opinion, Vol. 25, Iss. 2, 2009-02 ,pp. : 431-447

Informa Healthcare

Access to resources Recommend Favorite

Future approaches to reducing low-density lipoprotein cholesterol

By Wierzbicki Anthony S  

Future Lipidology, Vol. 1, Iss. 4, 2006-08 ,pp. : 463-476

Future Medicine

Access to resources Recommend Favorite